Kerna Labs co-founder Melissa Moore (L) and CEO Julia Peng
January 10, 2025 11:05 AM EST
Financing
Startups

Ex­clu­sive: Mod­er­na's for­mer top sci­en­tist has a new start­up us­ing AI to im­prove mR­NA ther­a­pies

Ryan Cross

Senior Science Correspondent

Melis­sa Moore helped ush­er in the first mR­NA med­i­cines, but the for­mer Mod­er­na ex­ec­u­tive thinks there’s still a lot of room for im­prove­ment.
The rapid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

Up­dat­ed: CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

Lil­ly fi­nances new $500M biotech fund man­aged by a16z

John Maraganore turns to ex-Al­ny­lam col­league to lead his lat­est RNAi bet; Amy­lyx names com­mer­cial chief

Ab­b­Vie writes off $3.5B on Cerev­el drug af­ter Phase 2 fail­ures

Pfiz­er touts blad­der can­cer re­sults as first ad­vance­ment for some pa­tients 'in decades'

A service from the Financial Times